Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C17H17ClO3 |
| Molecular Weight | 304.768 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(OCC1=CC=C(C=C1)C2=CC=C(Cl)C=C2)C(O)=O
InChI
InChIKey=UGOFYAXVVVXMQT-UHFFFAOYSA-N
InChI=1S/C17H17ClO3/c1-17(2,16(19)20)21-11-12-3-5-13(6-4-12)14-7-9-15(18)10-8-14/h3-10H,11H2,1-2H3,(H,19,20)
| Molecular Formula | C17H17ClO3 |
| Molecular Weight | 304.768 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Clobuzarit (Clozic) is a compound originally developed for the treatment of atherosclerosis. It was later found to possess antirheumatic and weak anti-inflammatory properties and was evaluated as a disease-modifying antirheumatic drug. Adverse side effects observed in clinical trials have forced the withdrawal of clobuzarit from further consideration.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:03:20 GMT 2023
by
admin
on
Fri Dec 15 16:03:20 GMT 2023
|
| Record UNII |
W3D7B06505
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Fri Dec 15 16:03:20 GMT 2023 , Edited by admin on Fri Dec 15 16:03:20 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
4736
Created by
admin on Fri Dec 15 16:03:20 GMT 2023 , Edited by admin on Fri Dec 15 16:03:20 GMT 2023
|
PRIMARY | |||
|
C78132
Created by
admin on Fri Dec 15 16:03:20 GMT 2023 , Edited by admin on Fri Dec 15 16:03:20 GMT 2023
|
PRIMARY | |||
|
71697
Created by
admin on Fri Dec 15 16:03:20 GMT 2023 , Edited by admin on Fri Dec 15 16:03:20 GMT 2023
|
PRIMARY | |||
|
100000084303
Created by
admin on Fri Dec 15 16:03:20 GMT 2023 , Edited by admin on Fri Dec 15 16:03:20 GMT 2023
|
PRIMARY | |||
|
DTXSID8020335
Created by
admin on Fri Dec 15 16:03:20 GMT 2023 , Edited by admin on Fri Dec 15 16:03:20 GMT 2023
|
PRIMARY | |||
|
SUB06681MIG
Created by
admin on Fri Dec 15 16:03:20 GMT 2023 , Edited by admin on Fri Dec 15 16:03:20 GMT 2023
|
PRIMARY | |||
|
CHEMBL164447
Created by
admin on Fri Dec 15 16:03:20 GMT 2023 , Edited by admin on Fri Dec 15 16:03:20 GMT 2023
|
PRIMARY | |||
|
W3D7B06505
Created by
admin on Fri Dec 15 16:03:20 GMT 2023 , Edited by admin on Fri Dec 15 16:03:20 GMT 2023
|
PRIMARY | |||
|
245-035-4
Created by
admin on Fri Dec 15 16:03:20 GMT 2023 , Edited by admin on Fri Dec 15 16:03:20 GMT 2023
|
PRIMARY | |||
|
m120
Created by
admin on Fri Dec 15 16:03:20 GMT 2023 , Edited by admin on Fri Dec 15 16:03:20 GMT 2023
|
PRIMARY | Merck Index | ||
|
22494-47-9
Created by
admin on Fri Dec 15 16:03:20 GMT 2023 , Edited by admin on Fri Dec 15 16:03:20 GMT 2023
|
PRIMARY | |||
|
3716
Created by
admin on Fri Dec 15 16:03:20 GMT 2023 , Edited by admin on Fri Dec 15 16:03:20 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
